AbbVie (Mexico) Buy Hold or Sell Recommendation
| ABBV Stock | MXN 2,804 15.07 0.53% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding AbbVie Inc is 'Cautious Hold'. Macroaxis provides AbbVie buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. The advice algorithm takes into account all of AbbVie's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting AbbVie's buy or sell advice are summarized below:
Real Value 2.8 K | Hype Value 2.8 K | Market Value 2.8 K |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell AbbVie Inc given historical horizon and risk tolerance towards AbbVie. When Macroaxis issues a 'buy' or 'sell' recommendation for AbbVie Inc, the advice is generated through an automated system that utilizes algorithms and statistical models.
AbbVie |
Execute AbbVie Buy or Sell Advice
The AbbVie recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on AbbVie Inc. Macroaxis does not own or have any residual interests in AbbVie Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute AbbVie's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
AbbVie Trading Alerts and Improvement Suggestions
| AbbVie Inc generated a negative expected return over the last 90 days | |
| The company has accumulated 64.19 B in total debt with debt to equity ratio (D/E) of 6.52, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AbbVie until it has trouble settling it off, either with new capital or with free cash flow. So, AbbVie's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AbbVie Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AbbVie to invest in growth at high rates of return. When we think about AbbVie's use of debt, we should always consider it together with cash and equity. | |
| About 71.0% of AbbVie shares are held by institutions such as insurance companies |
AbbVie Returns Distribution Density
The distribution of AbbVie's historical returns is an attempt to chart the uncertainty of AbbVie's future price movements. The chart of the probability distribution of AbbVie daily returns describes the distribution of returns around its average expected value. We use AbbVie Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of AbbVie returns is essential to provide solid investment advice for AbbVie.
| Mean Return | 0.04 | Value At Risk | -1.3 | Potential Upside | 1.65 | Standard Deviation | 0.98 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of AbbVie historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
AbbVie Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to AbbVie or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that AbbVie's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a AbbVie stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.03 | |
β | Beta against NYSE Composite | 0.09 | |
σ | Overall volatility | 0.97 | |
Ir | Information ratio | -0.04 |
AbbVie Volatility Alert
AbbVie Inc has relatively low volatility with skewness of -1.44 and kurtosis of 8.72. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure AbbVie's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact AbbVie's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.AbbVie Fundamentals Vs Peers
Comparing AbbVie's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AbbVie's direct or indirect competition across all of the common fundamentals between AbbVie and the related equities. This way, we can detect undervalued stocks with similar characteristics as AbbVie or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AbbVie's fundamental indicators could also be used in its relative valuation, which is a method of valuing AbbVie by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare AbbVie to competition |
| Fundamentals | AbbVie | Peer Average |
| Return On Equity | 0.75 | -0.31 |
| Return On Asset | 0.0927 | -0.14 |
| Profit Margin | 0.20 % | (1.27) % |
| Operating Margin | 0.39 % | (5.51) % |
| Current Valuation | 6.83 T | 16.62 B |
| Shares Outstanding | 1.77 B | 571.82 M |
| Shares Owned By Insiders | 0.11 % | 10.09 % |
| Shares Owned By Institutions | 70.81 % | 39.21 % |
| Price To Earning | 36.97 X | 28.72 X |
| Price To Book | 18.09 X | 9.51 X |
| Price To Sales | 99.47 X | 11.42 X |
| Revenue | 58.05 B | 9.43 B |
| Gross Profit | 41.49 B | 27.38 B |
| EBITDA | 18.81 B | 3.9 B |
| Net Income | 11.84 B | 570.98 M |
| Cash And Equivalents | 8.6 B | 2.7 B |
| Cash Per Share | 4.87 X | 5.01 X |
| Total Debt | 64.19 B | 5.32 B |
| Debt To Equity | 6.52 % | 48.70 % |
| Current Ratio | 0.91 X | 2.16 X |
| Book Value Per Share | 9.04 X | 1.93 K |
| Cash Flow From Operations | 22.78 B | 971.22 M |
| Earnings Per Share | 124.57 X | 3.12 X |
| Price To Earnings To Growth | 1.21 X | 4.89 X |
| Number Of Employees | 29 | 18.84 K |
| Beta | 0.58 | -0.15 |
| Market Capitalization | 5.06 T | 19.03 B |
| Total Asset | 146.53 B | 29.47 B |
| Z Score | 46.8 | 8.72 |
| Annual Yield | 0.04 % | |
| Five Year Return | 4.18 % | |
| Net Asset | 146.53 B | |
| Last Dividend Paid | 5.71 |
AbbVie Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as AbbVie . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 2803.98 | |||
| Day Typical Price | 2803.98 | |||
| Price Action Indicator | (7.54) | |||
| Period Momentum Indicator | (15.07) |
About AbbVie Buy or Sell Advice
When is the right time to buy or sell AbbVie Inc? Buying financial instruments such as AbbVie Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having AbbVie in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Staples ETFs Thematic Idea Now
Consumer Staples ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Staples ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Staples ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |